Eyestem raises Series A round led by three pharma majors
The investment will enable Eyestem to progress a treatment for dry age-related macular degeneration to the clinic
Recover your password.
A password will be e-mailed to you.
- Advertisement -
Recover your password.
A password will be e-mailed to you.